Schedule

R1 RCM Forms Special Committee to Evaluate Strategic Alternatives

Retrieved on: 
Monday, March 11, 2024

MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C.

Key Points: 
  • MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C.
  • Consistent with its fiduciary duties, and in consultation with its independent advisors, the Special Committee will carefully review the communications from New Mountain Capital and evaluate strategic alternatives to determine the course of action that it believes is in the best interests of R1 and its stockholders.
  • R1 remains focused on providing clients with world-class revenue cycle solutions to help providers improve their financial performance and deliver an exceptional patient experience.
  • No assurances can be given regarding the outcome or timing of the Special Committee’s review process.

Clarus Board of Directors Approves Two of Its Top Shareholders to Increase Their Positions up to 15.0% and 26.7% of Shares Outstanding

Retrieved on: 
Friday, March 8, 2024

Greenhouse and Kanders have been permitted to increase their positions to up to 15.0% and 26.7% of the Company’s outstanding shares of common stock, respectively.

Key Points: 
  • Greenhouse and Kanders have been permitted to increase their positions to up to 15.0% and 26.7% of the Company’s outstanding shares of common stock, respectively.
  • Greenhouse has beneficial ownership of 4,538,107 shares of the Company’s common stock, as publicly disclosed by Greenhouse in the Schedule 13G as of December 31, 2023, filed by it with the Securities and Exchange Commission on February 14, 2024, which represents approximately 11.9% of the Company’s outstanding shares of common stock.
  • Kanders has beneficial ownership of 6,525,421 shares of the Company’s common stock, as publicly disclosed by Kanders in the Schedule 13D/A filed with the Securities and Exchange Commission on January 30, 2024, which represents approximately 16.7% of the Company’s outstanding shares of common stock.
  • In the event that Greenhouse or Kanders subsequently reduces their respective beneficial ownership to below 9.9%, they would need to obtain a new approval from the Company’s board of directors before seeking to again increase their respective beneficial ownership to in excess of 9.9% of the Company’s outstanding shares of common stock.

DIRTT Announces Amendments to its Substantial Issuer Bid

Retrieved on: 
Wednesday, March 6, 2024

CALGARY, Alberta, March 05, 2024 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”) (TSX: DRT; OTC: DRTTF), a leader in industrialized construction, announced today that it has effected certain amendments to the Company's offer to purchase and accompanying issuer bid circular (the "Offer and Circular") dated February 15, 2024, in connection with its previously announced substantial issuer bid and tender offer (the "Issuer Bid").

Key Points: 
  • CALGARY, Alberta, March 05, 2024 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”) (TSX: DRT; OTC: DRTTF), a leader in industrialized construction, announced today that it has effected certain amendments to the Company's offer to purchase and accompanying issuer bid circular (the "Offer and Circular") dated February 15, 2024, in connection with its previously announced substantial issuer bid and tender offer (the "Issuer Bid").
  • This Notice of Variation should be read in conjunction with the Issuer Bid Documents (as defined herein).
  • DIRTT has retained Computershare Investor Services Inc. ("Computershare") to act as depositary for the Issuer Bid.
  • Debentureholders are urged to carefully read these materials prior to making any decision with respect to the Issuer Bid.

Global Partners LP Provides Update on Expected Availability of 2023 Tax Packages

Retrieved on: 
Friday, March 8, 2024

Global Partners LP (NYSE: GLP) (“Global” or the “Partnership”) today provided an update on the expected availability of the Partnership’s 2023 tax packages, which include the Schedule K-1 for preferred and common unitholders.

Key Points: 
  • Global Partners LP (NYSE: GLP) (“Global” or the “Partnership”) today provided an update on the expected availability of the Partnership’s 2023 tax packages, which include the Schedule K-1 for preferred and common unitholders.
  • 7024 legislation that includes changes in tax law which would be applied retroactively to the 2023 tax year.
  • 7024, Global will provide an update on the availability of the 2023 tax packages at www.globalp.com in the Investors section of the website.
  • Investors registered with Global Partners LP Tax Package Support at www.taxpackagesupport.com/globalpartners will receive notification when the 2023 tax packages are available.

USA Compression Partners Announces 2023 K-1 Tax Package Availability

Retrieved on: 
Wednesday, March 6, 2024

USA Compression Partners, LP (NYSE: USAC) (“USA Compression”) today announced that its 2023 tax packages, including the Schedule K-1, are now available online and may be accessed at taxpackagesupport.com/usac.

Key Points: 
  • USA Compression Partners, LP (NYSE: USAC) (“USA Compression”) today announced that its 2023 tax packages, including the Schedule K-1, are now available online and may be accessed at taxpackagesupport.com/usac.
  • USA Compression will begin the process of mailing the 2023 tax packages to unitholders over the next week.
  • In its current form, this legislation includes changes in tax law which would be applied retroactively to the 2023 tax year and may require USA Compression to issue revised 2023 Schedule K-1s if it does so.
  • 7024 is enacted, USA Compression will issue a press release to update unitholders on the availability of revised 2023 Schedule K-1s.

TDCX Inc. Enters into Definitive Merger Agreement for Going-Private Transaction

Retrieved on: 
Friday, March 1, 2024

The Company’s board of directors (the “Board”), acting upon the unanimous recommendation of a committee of independent and disinterested directors established by the Board (the “Special Committee”), approved the Merger Agreement and the Merger.

Key Points: 
  • The Company’s board of directors (the “Board”), acting upon the unanimous recommendation of a committee of independent and disinterested directors established by the Board (the “Special Committee”), approved the Merger Agreement and the Merger.
  • The Special Committee negotiated the terms of the Merger Agreement with the assistance of its financial and legal advisors.
  • The Company will furnish to the U.S. Securities and Exchange Commission (the “SEC”) a current report on Form 6-K regarding the Merger, which will include as an exhibit thereto the Merger Agreement.
  • In connection with the Merger, the Company will prepare and mail a Schedule 13E-3 Transaction Statement (the “Schedule 13E-3”) to its shareholders.

NuStar Energy L.P.’s Preferred Unit 2023 Schedule K-1 Tax Packages Now Available

Retrieved on: 
Friday, March 1, 2024

NuStar Energy L.P. (NYSE: NS) today announced that the 2023 tax packages for preferred units, which include the Schedule K-1’s for Series A, Series B and Series C preferred units, are available online at www.nustarenergy.com in the Investors section of the website.

Key Points: 
  • NuStar Energy L.P. (NYSE: NS) today announced that the 2023 tax packages for preferred units, which include the Schedule K-1’s for Series A, Series B and Series C preferred units, are available online at www.nustarenergy.com in the Investors section of the website.
  • The partnership expects to begin mailing the 2023 tax packages on March 6, 2024.
  • NuStar Energy L.P., through its subsidiaries (collectively, “NuStar” or the “Partnership”), is an independent liquids terminal and pipeline operator.
  • For more information, visit NuStar Energy L.P.’s website at www.nustarenergy.com and its Sustainability page at https://sustainability.nustarenergy.com/ .

NuStar Energy L.P.’s Update on Availability of 2023 Schedule K-1

Retrieved on: 
Friday, February 23, 2024

NuStar Energy L.P. (NYSE: NS) today provided an update on the expected availability of the Partnership’s 2023 tax packages, which include the Schedule K-1 for common units.

Key Points: 
  • NuStar Energy L.P. (NYSE: NS) today provided an update on the expected availability of the Partnership’s 2023 tax packages, which include the Schedule K-1 for common units.
  • 7024 legislation that includes changes in tax law which would be applied retroactively to the 2023 tax year.
  • 7024, NuStar will provide an update on the availability of the 2023 tax packages.
  • For more information, visit NuStar Energy L.P.’s website at www.nustarenergy.com and its Sustainability page at https://sustainability.nustarenergy.com/ .

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

Retrieved on: 
Friday, February 23, 2024

Germany is expected to pass the Cannabis Act today (Friday), heralding a transformative era for the medical cannabis industry.

Key Points: 
  • Germany is expected to pass the Cannabis Act today (Friday), heralding a transformative era for the medical cannabis industry.
  • The passage of the Cannabis Act represents a pivotal shift, primarily by making it substantially easier and more cost-effective for doctors to prescribe medical cannabis.
  • The Act's facilitation of the prescription process is anticipated to lead to a surge in demand for medical cannabis.
  • Looking ahead, Germany's Cannabis Act marks a significant milestone for the medical cannabis industry, promising to increase demand, expand the patient base, and reduce prices through heightened competition.

Nitazenes are a powerful class of street drugs emerging across the US

Retrieved on: 
Thursday, February 15, 2024

Researchers have relatively little information on how the human body reacts to nitazenes because the drugs have never gone through clinical trials.

Key Points: 
  • Researchers have relatively little information on how the human body reacts to nitazenes because the drugs have never gone through clinical trials.
  • As law enforcement has cracked down on other drugs such as fentanyl, illegal labs have used historical pharmacology research to formulate analogs of nitazenes as street drugs.
  • Although nitazenes are now identified as illegal street drugs in numerous countries, many medical providers aren’t even aware they exist.
  • Nitazenes are also mixed with other street drugs such as heroin and fentanyl and with fake oxycodone pills, without users knowing it.